Morepen Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morepen Laboratories Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.71 billion Indian Rupees [US$78.97 million]
Suven Life Sciences Limited
(6.25 billion Indian Rupees [US$86.47 million]
of which 95%
was Intermediaries under Contract Research/M), and
Novartis India Limited
(5.64 billion Indian Rupees [US$77.98 million]
of which 100%
Morepen Laboratories Limited reported sales of 6.07 billion Indian Rupees (US$83.88 million)
March of 2018.
increase of 3.9%
versus 2017, when the company's sales were 5.84 billion Indian Rupees.
Sales at Morepen Laboratories Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 91%).